Taizhou Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer4 trials
• COPD1 trial
• Lung cancer1 trial

Phase

• Phase 25 trials

Status

• Not yet recruiting4 trials
• Active, not recruiting2 trials

Lead sponsor

• Yu jiren4 trials
• Elpiscience (Suzhou) Biopharma, Ltd.1 trial
• Second Affiliated Hospital, Zhejiang University, School of Medicine1 trial

Running trials

• Not yet recruiting

  Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD

  NCT07665359· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source

  Contact: Junfei Zhu

• Active, not recruiting

  A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer

  NCT06623136· Phase 2· Elpiscience (Suzhou) Biopharma, Ltd.· Source

• Recruiting

  Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)

  NCT05872685· Phase 2· Yu jiren· Source

  Contact: Shenkang Zhou

• Not yet recruiting

  Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

  NCT05970627· Phase 2· Yu jiren· Source

  Contact: Shenkang Zhou

• Recruiting

  Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

  NCT05729646· Phase 2· Yu jiren· Source

  Contact: Shenkang Zhou

• Active, not recruiting

  Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

  NCT05715931· Phase 2· Yu jiren· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and oesophageal cancer3 recruiting
• COPD1 recruiting